(The Gist of PIB) Human Monoclonal Antibodies (hmAbs) [MAY-2020]
(The Gist of PIB) Human Monoclonal Antibodies(hmAbs)
Human Monoclonal Antibodies(hmAbs)
Council of Scientific and Industrial Research (CSIR) through its New Millennium Indian Technology Leadership Initiative (NMITLI) program has approved a project towards the development of human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients.
The project aims to generate hmAbs to SARS-CoV-2 from the convalescent phase of COVID-19 patients and select high affinity and neutralizing antibodies.
The project also aims to anticipate future adaptation of the virus and generate hmAbs clones that can neutralize the mutated virus so that it could be readily used for combating future SARS-CoV infections.
The project will be implemented by the National Centre for Cell Science (NCCS), IIT-Indore, and PredOmix Technologies Pvt. Ltd. with Bharat Biotech International Ltd. (BBIL) as the commercialization partner.